日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populations

药物和单细胞基因表达整合可识别对药物敏感和耐药的胶质母细胞瘤细胞群

Suter, Robert K; Jermakowicz, Anna M; Veeramachaneni, Rithvik; D'Antuono, Matthew; Zhang, Longwei; Chowdary, Rishika; Kaeppeli, Simon; Sharp, Madison; Palwai, Pravallika; Stathias, Vasileios; Baker, Grace; Ruiz, Luz; Walters, Winston; Cepero, Maria; Burgenske, Danielle; Reilly, Edward B; Oleksijew, Anatol; Anderson, Mark G; Williams, Sion Ll; Ivan, Michael E; Komotar, Ricardo J; De La Fuente, Macarena I; Stein, Gregory; Wojcinski, Alexandre; Kesari, Santosh; Sarkaria, Jann N; Schürer, Stephan C; Ayad, Nagi G

DRUG AND SINGLE-CELL GENE EXPRESSION INTEGRATION IDENTIFIES SENSITIVE AND RESISTANT GLIOBLASTOMA CELL POPULATIONS

药物和单细胞基因表达整合可识别敏感和耐药的胶质母细胞瘤细胞群

Suter, Robert K; Jermakowicz, Anna M; Veeramachaneni, Rithvik; D'Antuono, Matthew; Zhang, Longwei; Chowdary, Rishika; Kaeppeli, Simon; Sharp, Madison; Palwai, Pravallika; Stathias, Vasileios; Baker, Grace; Ruiz, Luz; Walters, Winston; Cepero, Maria; Burgenske, Danielle; Reilly, Edward B; Oleksijew, Anatol; Anderson, Mark G; Williams, Sion Ll; Ivan, Michael E; Komotar, Ricardo J; De La Fuente, Macarena I; Stein, Gregory; Wojcinski, Alexander; Kesari, Santosh; Sarkaria, Jann N; Schürer, Stephan C; Ayad, Nagi G

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting

CD3×CD20双特异性抗体epcoritamab在慢性淋巴细胞白血病(CLL)中的细胞毒性可通过同时靶向BTK或BCL-2而增强。

Mhibik, Maissa; Gaglione, Erika M; Eik, David; Herrick, John; Le, Janet; Ahn, Inhye E; Chiu, Christopher; Wielgos-Bonvallet, Monica; Hiemstra, Ida H; Breij, Esther C W; Chen, Jenny; Reilly, Edward B; Epling-Burnette, Pearlie K; Szafer-Glusman, Edith; Sun, Clare; Wiestner, Adrian

Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma

抗表皮生长因子受体抗体药物偶联物serclutamab talirine的I期研究:在晚期胶质母细胞瘤中的安全性、药代动力学和抗肿瘤活性

Carneiro, Benedito A; Papadopoulos, Kyriakos P; Strickler, John H; Lassman, Andrew B; Waqar, Saiama N; Chae, Young Kwang; Patel, Jyoti D; Shacham-Shmueli, Einat; Kelly, Karen; Khasraw, Mustafa; Bestvina, Christine M; Merrell, Ryan; Huang, Kevin; Atluri, Harisha; Ansell, Peter; Li, Rachel; Jin, Janet; Anderson, Mark G; Reilly, Edward B; Morrison-Thiele, Gladys; Patel, Kalpesh; Robinson, Randy R; Aristide, Martha R Neagu; Gan, Hui K

Biodistribution Analysis of an Anti-EGFR Antibody in the Rat Brain: Validation of CSF Microcirculation as a Viable Pathway to Circumvent the Blood-Brain Barrier for Drug Delivery.

抗 EGFR 抗体在大鼠脑内的生物分布分析:验证脑脊液微循环是绕过血脑屏障进行药物递送的可行途径

Naseri Kouzehgarani Ghazal, Kumar Pankaj, Bolin Susan E, Reilly Edward B, Lefebvre Didier R

Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts

对流增强递送靶向 EGFR 的抗体药物偶联物 Serclutamab talirine 和 Depatux-M 在胶质母细胞瘤患者来源的异种移植模型中的作用

Porath, Kendra A; Regan, Michael S; Griffith, Jessica I; Jain, Sonia; Stopka, Sylwia A; Burgenske, Danielle M; Bakken, Katrina K; Carlson, Brett L; Decker, Paul A; Vaubel, Rachael A; Dragojevic, Sonja; Mladek, Ann C; Connors, Margaret A; Hu, Zeng; He, Lihong; Kitange, Gaspar J; Gupta, Shiv K; Feldsien, Thomas M; Lefebvre, Didier R; Agar, Nathalie Y R; Eckel-Passow, Jeanette E; Reilly, Edward B; Elmquist, William F; Sarkaria, Jann N